Related references
Note: Only part of the references are listed.Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection
Peter Hraber et al.
AIDS (2014)
Emergence of Broadly Neutralizing Antibodies and Viral Coevolution in Two Subjects during the Early Stages of Infection with Human Immunodeficiency Virus Type 1
D. Noah Sather et al.
JOURNAL OF VIROLOGY (2014)
Characterization and Immunogenicity of a Novel Mosaic M HIV-1 gp140 Trimer
Joseph P. Nkolola et al.
JOURNAL OF VIROLOGY (2014)
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
Nicole A. Doria-Rose et al.
NATURE (2014)
DNA and Protein Co-Immunization Improves the Magnitude and Longevity of Humoral Immune Responses in Macaques
Rashmi Jalah et al.
PLOS ONE (2014)
Soluble HIV-1 Envelope Immunogens Derived from an Elite Neutralizer Elicit Cross-Reactive V1V2 Antibodies and Low Potency Neutralizing Antibodies
Sara Carbonetti et al.
PLOS ONE (2014)
Improvement of antibody responses by HIV envelope DNA and protein co-immunization
Franco Pissani et al.
VACCINE (2014)
Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies
Andrew T. McGuire et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Pegylated Interferon Alfa-2a Monotherapy Results in Suppression of HIV Type 1 Replication and Decreased Cell-Associated HIV DNA Integration
Livio Azzoni et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Multiple Pathways of Escape from HIV Broadly Cross-Neutralizing V2-Dependent Antibodies
Penny L. Moore et al.
JOURNAL OF VIROLOGY (2013)
Robust Neutralizing Antibodies Elicited by HIV-1 JRFL Envelope Glycoprotein Trimers in Nonhuman Primates
Bimal K. Chakrabarti et al.
JOURNAL OF VIROLOGY (2013)
Antigenicity and Immunogenicity of Transmitted/Founder, Consensus, and Chronic Envelope Glycoproteins of Human Immunodeficiency Virus Type 1
Hua-Xin Liao et al.
JOURNAL OF VIROLOGY (2013)
Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia
Masashi Shingai et al.
NATURE (2013)
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys
Dan H. Barouch et al.
NATURE (2013)
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
Hua-Xin Liao et al.
NATURE (2013)
Prime-Boost Immunization of Rabbits with HIV-1 gp120 Elicits Potent Neutralization Activity against a Primary Viral Isolate
Kristin M. Narayan et al.
PLOS ONE (2013)
Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC/AIDSVAX HIV-1 Vaccine Efficacy Trial
Susan Zolla-Pazner et al.
PLOS ONE (2013)
HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity
Tom L. G. M. van den Kerkhof et al.
RETROVIROLOGY (2013)
Delineating Antibody Recognition in Polyclonal Sera from Patterns of HIV-1 Isolate Neutralization
Ivelin S. Georgiev et al.
SCIENCE (2013)
Antibodies in HIV-1 Vaccine Development and Therapy
Florian Klein et al.
SCIENCE (2013)
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
Joseph Jardine et al.
SCIENCE (2013)
HIV/SIV DNA vaccine combined with protein in a co-immunization protocol elicits highest humoral responses to envelope in mice and macaques
Jinyao Li et al.
VACCINE (2013)
Viral Escape from HIV-1 Neutralizing Antibodies Drives Increased Plasma Neutralization Breadth through Sequential Recognition of Multiple Epitopes and Immunotypes
Constantinos Kurt Wibmer et al.
PLOS PATHOGENS (2013)
Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs
Sam Hoot et al.
PLOS PATHOGENS (2013)
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
Rogier W. Sanders et al.
PLOS PATHOGENS (2013)
Requirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine
Marc H. V. Van Regenmortel
ARCHIVES OF VIROLOGY (2012)
The Development of CD4 Binding Site Antibodies during HIV-1 Infection
Rebecca M. Lynch et al.
JOURNAL OF VIROLOGY (2012)
Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2
Morgane Rolland et al.
NATURE (2012)
Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape
Penny L. Moore et al.
NATURE MEDICINE (2012)
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Barton F. Haynes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Co-Immunization with Multimeric Scaffolds and DNA Rapidly Induces Potent Autologous HIV-1 Neutralizing Antibodies and CD8+ T Cells
Juan Pablo Jaworski et al.
PLOS ONE (2012)
Evolution of Cross-Neutralizing Antibody Specificities to the CD4-BS and the Carbohydrate Cloak of the HIV Env in an HIV-1-Infected Subject
Iliyana Mikell et al.
PLOS ONE (2012)
Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120
Anthony P. West et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
High-Resolution Definition of Vaccine-Elicited B Cell Responses Against the HIV Primary Receptor Binding Site
Christopher Sundling et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Motif-optimized subtype A HIV envelope-based DNA vaccines rapidly elicit neutralizing antibodies when delivered sequentially
Franco Pissani et al.
VACCINE (2012)
Use of a polyanionic carbomer, Carbopol971P, in combination with MF59, improves antibody responses to HIV-1 envelope glycoprotein
Antu K. Dey et al.
VACCINE (2012)
Lessons in Nonhuman Primate Models for AIDS Vaccine Research: From Minefields to Milestones
Jeffrey D. Lifson et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Differences in Antibody Responses of Individuals with Natural Infection and Those Vaccinated against Pandemic H1N1 2009 Influenza
Kwok-Hung Chan et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Limitations to the structure-based design of HIV-1 vaccine immunogens
Marc H. V. Van Regenmortel
JOURNAL OF MOLECULAR RECOGNITION (2011)
Cross-Clade HIV-1 Neutralizing Antibodies Induced with V3-Scaffold Protein Immunogens following Priming with gp120 DNA
Susan Zolla-Pazner et al.
JOURNAL OF VIROLOGY (2011)
Binding Interactions between Soluble HIV Envelope Glycoproteins and Quaternary-Structure-Specific Monoclonal Antibodies PG9 and PG16
Thaddeus M. Davenport et al.
JOURNAL OF VIROLOGY (2011)
The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection
Elin S. Gray et al.
JOURNAL OF VIROLOGY (2011)
Sequential Immunization with a Subtype B HIV-1 Envelope Quasispecies Partially Mimics the In Vivo Development of Neutralizing Antibodies
Delphine C. Malherbe et al.
JOURNAL OF VIROLOGY (2011)
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
Jason S. McLellan et al.
NATURE (2011)
Broad neutralization coverage of HIV by multiple highly potent antibodies
Laura M. Walker et al.
NATURE (2011)
Prospects for an HIV vaccine: leading B cells down the right path
Susan Moir et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody
Dennis R. Burton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1
Iliyana Mikell et al.
PLOS PATHOGENS (2011)
Neutralizing Antibodies and Control of HIV: Moves and Countermoves
Ann J. Hessell et al.
Current HIV/AIDS Reports (2011)
The Role of Antibodies in HIV Vaccines
John R. Mascola et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Toward an Antibody-Based HIV-1 Vaccine
James A. Hoxie
ANNUAL REVIEW OF MEDICINE (2010)
Soluble HIV-1 Env trimers in adjuvant elicit potent and diverse functional B cell responses in primates
Christopher Sundling et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Comparative Immunogenicity of Subtype A Human Immunodeficiency Virus Type 1 Envelope Exhibiting Differential Exposure of Conserved Neutralization Epitopes
Catherine A. Blish et al.
JOURNAL OF VIROLOGY (2010)
Breadth of Human Immunodeficiency Virus-Specific Neutralizing Activity in Sera: Clustering Analysis and Association with Clinical Variables
Nicole A. Doria-Rose et al.
JOURNAL OF VIROLOGY (2010)
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
Tongqing Zhou et al.
SCIENCE (2010)
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Xueling Wu et al.
SCIENCE (2010)
Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies
S. Gnanakaran et al.
PLOS COMPUTATIONAL BIOLOGY (2010)
Frequency and Phenotype of Human Immunodeficiency Virus Envelope-Specific B Cells from Patients with Broadly Cross-Neutralizing Antibodies
Nicole A. Doria-Rose et al.
JOURNAL OF VIROLOGY (2009)
Human Immunodeficiency Virus Type 1 Env Trimer Immunization of Macaques and Impact of Priming with Viral Vector or Stabilized Core Protein
Andreas Moerner et al.
JOURNAL OF VIROLOGY (2009)
Factors Associated with the Development of Cross-Reactive Neutralizing Antibodies during Human Immunodeficiency Virus Type 1 Infection
D. Noah Sather et al.
JOURNAL OF VIROLOGY (2009)
Analysis of Neutralization Specificities in Polyclonal Sera Derived from Human Immunodeficiency Virus Type 1-Infected Individuals
Yuxing Li et al.
JOURNAL OF VIROLOGY (2009)
Continuous Viral Escape and Selection by Autologous Neutralizing Antibodies in Drug-Naive Human Immunodeficiency Virus Controllers
Madhumita Mahalanabis et al.
JOURNAL OF VIROLOGY (2009)
Preclinical Studies of Human Immunodeficiency Virus/AIDS Vaccines: Inverse Correlation between Avidity of Anti-Env Antibodies and Peak Postchallenge Viremia
Jun Zhao et al.
JOURNAL OF VIROLOGY (2009)
Breadth of Neutralizing Antibody Response to Human Immunodeficiency Virus Type 1 Is Affected by Factors Early in Infection but Does Not Influence Disease Progression
Anne Piantadosi et al.
JOURNAL OF VIROLOGY (2009)
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
Johannes F. Scheid et al.
NATURE (2009)
Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?
Leonidas Stamatatos et al.
NATURE MEDICINE (2009)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
Laura M. Walker et al.
SCIENCE (2009)
Improving the expression of recombinant soluble HIV Envelope glycoproteins using pseudo-stable transient transfection
George Sellhorn et al.
VACCINE (2009)
Limited Neutralizing Antibody Specificities Drive Neutralization Escape in Early HIV-1 Subtype C Infection
Penny L. Moore et al.
PLOS PATHOGENS (2009)
Characterization of neutralizing antibody responses elicited by clade a envelope immunogens derived from early transmitted viruses
Zane Kraft et al.
JOURNAL OF VIROLOGY (2008)
Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C
James M. Binley et al.
JOURNAL OF VIROLOGY (2008)
Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing
Jesus F. Salazar-Gonzalez et al.
JOURNAL OF VIROLOGY (2008)
B Cell Recognition of the Conserved HIV-1 Co-Receptor Binding Site Is Altered by Endogenous Primate CD4
Mattias N. E. Forsell et al.
PLOS PATHOGENS (2008)
Isolation and characterization of monoclonal antibodies elicited by trimeric HIV-1 Env gp140 protein immunogens
Nina R. Derby et al.
VIROLOGY (2007)
Rational modifications of HIV-1 envelope glycoproteins for immunogen design
S. Phogat et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity
Manish Sagar et al.
JOURNAL OF VIROLOGY (2006)
Consistent patterns of change during the divergence of human immunodeficiency virus type 1 envelope from that of the inoculated virus in simian/human immunodeficiency virus-infected macaques
WM Blay et al.
JOURNAL OF VIROLOGY (2006)
Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection
SDW Frost et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Relative-entropy algorithm for genomic fingerprinting captures host-phage similarities
H Robins et al.
JOURNAL OF BACTERIOLOGY (2005)
Purification, characterization, and immunogenicity of a soluble trimeric envelope protein containing a partial deletion of the V2 loop derived from SF162, an R5-tropic human immunodeficiency virus type 1 isolate
IK Srivastava et al.
JOURNAL OF VIROLOGY (2003)
Simultaneous immunization with DNA and protein vaccines against Japanese encephalitis or dengue synergistically increases their own abilities to induce neutralizing antibody in mice
E Konishi et al.
VACCINE (2003)
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
DD Richman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Antibody neutralization and escape by HIV-1
XP Wei et al.
NATURE (2003)
The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of α1→2 mannose residues on the outer face of gp120
CN Scanlan et al.
JOURNAL OF VIROLOGY (2002)
Share Paper
